Publications & Guidelines

Since 2004, the Publications Committee has been charged with developing and publishing various publications, including the SMFM Consult Series and the SMFM Clinical Guidelines series published in the American Journal of Obstetrics & Gynecology. The Publications Committee collaborates with other Societies and Colleges to develop joint publications and statements, as appropriate. The Committee plans topics, selects authors, and reviews each completed paper before it is submitted for an internal SMFM review process and then for publication.  All Committee members have filed conflict of interest statements with SMFM. Any conflicts have been resolved through a process approved by the Executive Board. To facilitate transparency in SMFM's guideline development process, a brief overview of the key stages in development is provided here. Feedback for SMFM Publications is welcome at pubs@smfm.org

Coding : Coding Tips Coding : Coding White Papers Press Publications & Guidelines Publications & Guidelines : Administrative Publications & Guidelines : Consult Series Publications & Guidelines : Endorsed Partner Pub Publications & Guidelines : Health Policy Publication Publications & Guidelines : Joint Publication Publications & Guidelines : Obstetric Care Consensus Publications & Guidelines : Public/Global Health Publications & Guidelines : SMFM Special Report Publications & Guidelines : SMFM Statement

Practice guideline from the AAN, AES, and SMFM
Practice guideline from the AAN, AES, and SMFM

Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication Continue Reading

Date posted05/15/2024


Update on Criteria for Suspected Diagnosis of Intraamniotic Infection
Update on Criteria for Suspected Diagnosis of Intraamniotic Infection

The Society for Maternal-Fetal Medicine endorses this Clinical Practice Update. Continue Reading

Date posted04/29/2024


Biomarker Prediction of Preeclampsia With Severe Features
Biomarker Prediction of Preeclampsia With Severe Features

Abstract This Clinical Practice Update provides guidance for the use of a biomarker immunoassay to aid in the risk assessment of certain pregnant women hospitalized for hypertensive disorders for the progression to preeclampsia with severe features. This document updates Practice Bulletin No.... Continue Reading

Postedby Society For Maternal-Fetal Medicine
Date posted04/3/2024


Measles and Pregnancy: What Maternal-Fetal Medicine Subspecialists Need to Know
Measles and Pregnancy: What Maternal-Fetal Medicine Subspecialists Need to Know

Measles, also known as rubeola, is a preventable, highly contagious, acute febrile viral illness and an important cause of mortality and morbidity. As of March 21, 2024, 64 measles cases have been reported by 17 jurisdictions (Arizona, California, Florida, Georgia, Illinois, Indiana, Louisiana,... Continue Reading

Date posted03/29/2024


Operative vaginal delivery: checklists for performance and documentation
Operative vaginal delivery: checklists for performance and documentation

The frequency of operative vaginal delivery has been declining, even though it can be an attractive alternative to cesarean delivery in selected cases. Performance of operative vaginal delivery requires consideration of many indications, contraindications, and prerequisites. Optimal documentation... Continue Reading

Date posted01/1/2024


Current Approaches to Measuring Quality of Care in Obstetrics
Current Approaches to Measuring Quality of Care in Obstetrics

Heath care measurement and evaluation is an integral piece of the health care system. The creation and assessment of care performance metrics are important and relevant for the obstetric community including both clinicians and patients. Careful deliberation is required to create a measurement... Continue Reading

Date posted01/1/2024


RhD immune globulin after spontaneous or induced abortion less than 12 weeks of gestation
RhD immune globulin after spontaneous or induced abortion less than 12 weeks of gestation

Abstract: Guidelines for the management of first-trimester spontaneous and induced abortion vary regarding RhD testing and Rho(D) immune globulin administration. These existing guidelines are based on limited data that do not convincingly demonstrate the safety of withholding Rho(D) immune... Continue Reading

Date posted01/1/2024


A report and recommendations of the workshop of the Society for Maternal-Fetal Medicine
A report and recommendations of the workshop of the Society for Maternal-Fetal Medicine

This article is a report of a 2-day workshop, entitled “Social determinants of health and obstetric outcomes,” held during the Society for Maternal-Fetal Medicine 2022 Annual Pregnancy Meeting. Participants’ fields of expertise included obstetrics, pediatrics, epidemiology,... Continue Reading

Date posted12/30/2023


SMFM Consult #69: Hepatitis B in pregnancy: updated guidelines
SMFM Consult #69: Hepatitis B in pregnancy: updated guidelines

Abstract More than 290 million people worldwide, and almost 2 million people in the United States, are infected with hepatitis B virus, which can lead to chronic hepatitis B, a vaccine-preventable communicable disease. The prevalence of chronic hepatitis B infection in pregnancy is estimated to... Continue Reading

Date posted12/21/2023


ACOG Practice Advisory: Maternal Respiratory Syncytial Virus Vaccination
ACOG Practice Advisory: Maternal Respiratory Syncytial Virus Vaccination

This Practice Advisory was developed by the American College of Obstetricians and Gynecologists with the assistance of Kevin A. Ault, MD, Brenna L. Hughes, MD, and Laura E. Riley, MD. This Practice Advisory provides guidance for the use of respiratory syncytial virus (RSV) vaccine during... Continue Reading

Date posted12/15/2023


ACOG Committee Statement: Influenza in Pregnancy: Prevention and Treatment
ACOG Committee Statement: Influenza in Pregnancy: Prevention and Treatment

Abstract Pregnant and postpartum individuals are at significantly higher risk of serious complications related to seasonal and pandemic influenza infections compared with nonpregnant people. The Centers for Disease Control and Prevention and the American College of Obstetricians and Gynecologists... Continue Reading

Date posted12/1/2023


SMFM Consult #68: Sickle Cell Disease in Pregnancy
SMFM Consult #68: Sickle Cell Disease in Pregnancy

Abstract Pregnant individuals with sickle cell disease have an increased risk of maternal and perinatal morbidity and mortality. However, pre-pregnancy counseling and multidisciplinary care can lead to favorable maternal and neonatal outcomes. In this Consult, we summarize what is known about... Continue Reading

Date posted11/20/2023